Title of article :
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
Author/Authors :
Paul Emery، نويسنده , , Ferdinand C Breedveld، نويسنده , , Stephen Hall، نويسنده , , Patrick Durez، نويسنده , , David J Chang، نويسنده , , Deborah Robertson، نويسنده , , Amitabh Singh، نويسنده , , Ronald D Pedersen، نويسنده , , Andrew S Koenig، نويسنده , , Bruce Freundlich، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2008
Pages :
8
From page :
375
To page :
382
Abstract :
Summary Background Remission and radiographic non-progression are goals in the treatment of early rheumatoid arthritis. The aim of the combination of methotrexate and etanercept in active early rheumatoid arthritis (COMET) trial is to compare remission an
Journal title :
The Lancet
Serial Year :
2008
Journal title :
The Lancet
Record number :
593257
Link To Document :
بازگشت